60 Day FRN

27155

Federal Register / Vol. 87, No. 88 / Friday, May 6, 2022 / Notices
standards published by organizations
such as the American National
Standards Institute (ANSI), American
Society for Testing and Materials
(ASTM) International, and International
Organization for Standardization (ISO).
Thus, the information collected from
human subjects in a laboratory setting is
generally consistent across NPPTL
studies with only the boundary
conditions changing (e.g.,
environmental conditions such as heat
or humidity, human subject activity

NIOSH estimates that up to 1,500
individuals could be burdened per year.
Recruitment for all laboratory studies
includes individuals from the general
population rather than specific
industries or working status. These
individuals are all adults between the
ages of 18 and 65 years. CDC requests
OMB approval for an estimated 11,903
annual burden hours. There is no cost
to respondents other than their time to
participate.

such as simulated surgery or climbing a
ladder, and distance between two
subjects communicating by spoken
word). Additionally, novel PPT designs
may be examined or compared to
commercially available products under
similar boundary conditions to examine
adherence to regulations and/or
standards. NPPTL requests a new
Generic information collection package
for laboratory-collected information for
testing respirators and personal
protective clothing.

ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondents
Members of the
general public.

Total ..............

470

1

30/60

235

Health Screening Questionnaire ...................................
Demographics Questionnaire .......................................
Job-related Data: Occupational Tasks, postures used,
duration of exposure.
Physiological Measurements: Chest-worn heart rate
monitor strap, COSMED Kb5, SQ2020–1F8 temperature logger, TOSCA 500 pulse oximeter, koken
breathing waveform recording mask.
Biological Measurements: Cortisol (stress) levels,
pregnancy tests, hydration status, lipids, inflammatory markers, heat shock proteins.
Anthropometric Measurements: Calipers/digital measuring of facial and body dimensions.
Respirator Fit Measurements: Filter cassettes with air
pumps, fit-testing equipment, QLFT/sodium saccharin solution.
Self-Perception Data: Level of exertion, perceived
comfort level, heat sensation, fatigue.
Biomechanics Measurements: Force plate, stopwatch,
accelerometers.

470
470
470

6
1
1

1
30/60
15/60

2820
235
118

200

6

1.5

1800

100

6

15/60

150

500

1

15/60

125

225

100

15/60

5,625

500

6

15/60

750

30

3

30/60

45

........................

........................

........................

11,903

.......................................................................................

[FR Doc. 2022–09784 Filed 5–5–22; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–22–22ET; Docket No. CDC–2022–
0060]
JSPEARS on DSK121TN23PROD with NOTICES1

Total burden
(in hours)

Informed Consent .........................................................

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.

Proposed Data Collection Submitted
for Public Comment and
Recommendations

18:02 May 05, 2022

Jkt 256001

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled Traveler-based
SARS–CoV–2 Genomic Surveillance.
The information collection will monitor
for the importation of SARS–CoV–2
variants among arriving international air
travelers at select U.S. airports.

SUMMARY:

CDC must receive written
comments on or before July 5, 2022.

DATES:

Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

VerDate Sep<11>2014

Average
burden per
response
(in hours)

Number of
responses per
respondent

Number of
respondents

Form name

You may submit comments,
identified by Docket No. CDC–2022–
0060 by either of the following methods:

ADDRESSES:

PO 00000

Frm 00074

Fmt 4703

Sfmt 4703

• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and

E:\FR\FM\06MYN1.SGM

06MYN1

27156

Federal Register / Vol. 87, No. 88 / Friday, May 6, 2022 / Notices

Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the

information about the transmissibility,
virulence, and effectiveness of existing
vaccines, diagnostics, and therapeutics.
The project is conducted with external
partners and groups within DGMQ and
across CDC, including the Office of
Advanced Molecular Detection. The
program began at New York’s John F.
Kennedy International Airport in
September 2021 and later expanded to
include Newark Liberty International,
San Francisco International, and
Hartsfield-Jackson Atlanta International
airports. Information collection for this
project is currently approved under a
Public Health Emergency PRA Waiver.
Project data is collected as follows: A
volunteer sample of travelers, 18 years
and older, from selected flights from
South Asia, South America, Europe, and
southern Africa, complete an informed
consent form and fill-out a
questionnaire on enrollment at the
airport. The questionnaire includes
demographic, travel, and clinical
information. The voluntary surveillance
project also includes laboratory data
collection as follows: Airport collection
of nasal samples from arriving travelers
and follow-up collection of individual
at-home saliva samples 3–5 days later.
Travelers participating in individual, at
home sample collection also complete
an electronic health information
questionnaire prior to submission of
their samples and have the opportunity
to fill out an evaluation survey.
CDC requests OMB approval for an
estimated 169,433 annual burden hours.
There is no cost to respondents other
than their time to participate.

use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Traveler-based SARS–CoV–2
Genomic Surveillance—New—National
Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
The traveler-based SARS–CoV–2
genomic surveillance project was
developed as a surveillance platform for
early detection of imported and
emerging SARS–CoV–2 variants among
international air travelers arriving into
the United States. Despite layered
mitigation measures, international travel
facilitates spread of SARS–CoV–2,
including novel variants of concern
(VOCs). Although SARS–CoV–2
genomic sequencing has increased
significantly during the pandemic, there
is still a gap in early detection of
emerging variants among arriving
travelers.
To address this gap, in September
2021, the Travelers’ Health Branch, in
collaboration with private partners,
implemented a voluntary SARS–CoV–2
genomic surveillance program with the
goal of early detection of novel VOCs.
Surveillance for new and emerging
variant strains among travelers can
provide researchers and public health
officials critical time to collect

JSPEARS on DSK121TN23PROD with NOTICES1

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Average
burden per
response
(in hours)

Number of
responses per
respondent

Total
burden
(in hours)

Type of respondents

Form name

Participant with sample collected inairport.
Participant with sample collected at
home.
Participant with sample collection athome.

Participant information intake form
(for pooled testing).
Participant intake form (for individual
at-home testing).
Evaluation Survey Form ...................

88,400

1

1

88,400

44,200

1

1.5

66,300

44,200

1

20/60

14,733

Total ...........................................

...........................................................

........................

........................

........................

169,433

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–09786 Filed 5–5–22; 8:45 am]
BILLING CODE 4163–18–P

VerDate Sep<11>2014

18:02 May 05, 2022

Jkt 256001

PO 00000

Frm 00075

Fmt 4703

Sfmt 9990

E:\FR\FM\06MYN1.SGM

06MYN1